首页 > 最新文献

Journal of Ayurveda and Integrative Medicine最新文献

英文 中文
Exploring the interaction hotspots of p-glycoprotein with herbal bioactives: In silico insights for integrative Ayurvedic therapeutics 探索p-糖蛋白与草药生物活性的相互作用热点:阿育吠陀综合治疗的计算机洞察。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 Epub Date: 2025-10-29 DOI: 10.1016/j.jaim.2025.101238
Chandana Roy, Pratiti Ghosh

Background

The human multidrug resistant efflux transporter p-glycoprotein plays a crucial role in the pharmacokinetics of xenobiotics, mediating their elimination from systemic circulation. Its overexpression contributes to multidrug resistance, posing challenges to effective therapeutic interventions.

Objectives

This study integrates Ayurvedic and contemporary biomedical research to investigate hotspot residues involved in the interaction of p-glycoprotein with bioactives from medicinal herbs to enhance the understanding of its substrate recognition and transport mechanisms.

Material and methods

The 3D structure of 6C0V was docked with 789 herbal ligand molecules utilizing the CDOCKER programme in Biovia Discovery Studio (version 4.5, 2021), revealing key residues involved in binding interactions. Alanine scanning mutagenesis was performed to evaluate the functional importance of these residues by analyzing changes in binding affinity through molecular docking.

Result

The study identified residues Ser979, Glu972, Leu332, Phe336, Leu976, Thr76, Leu975, Gly737 and Phe732 as potential hotspots for binding and inhibition of ligand efflux into the extracellular compartment. Targeting these energetically important residues with herbal compounds can guide the development of small-molecule drugs that bind with high specificity and reduce off-target interactions, minimizing undesirable side effects.

Conclusion

This study provides insight into the structural basis of p-glycoprotein-herbal ligand interactions, aiding in the design of specific plant-based inhibitors for overcoming multidrug resistance in treatment of chronic diseases.
背景:人类多药耐药外排转运蛋白p-糖蛋白在外源药物的药代动力学中起着至关重要的作用,介导其从体循环中消除。它的过表达导致多药耐药,对有效的治疗干预提出了挑战。目的:本研究结合阿育吠陀医学和当代生物医学研究,研究p-糖蛋白与中草药生物活性相互作用的热点残基,以加深对其底物识别和转运机制的理解。材料和方法:利用Biovia Discovery Studio(版本4.5,2021)的CDOCKER程序,将6C0V的3D结构与789种草药配体分子对接,揭示了参与结合相互作用的关键残基。通过分子对接分析结合亲和力的变化,利用丙氨酸扫描诱变来评价这些残基的功能重要性。结果:研究发现Ser979、Glu972、Leu332、Phe336、Leu976、Thr76、Leu975、Gly737和Phe732等残基是结合和抑制配体外排进入细胞外室的潜在热点。用草药化合物靶向这些能量上重要的残基可以指导小分子药物的开发,这些药物具有高特异性结合,减少脱靶相互作用,最大限度地减少不良副作用。结论:本研究揭示了p-糖蛋白-草药配体相互作用的结构基础,有助于设计特异性植物抑制剂来克服慢性疾病治疗中的多药耐药。
{"title":"Exploring the interaction hotspots of p-glycoprotein with herbal bioactives: In silico insights for integrative Ayurvedic therapeutics","authors":"Chandana Roy,&nbsp;Pratiti Ghosh","doi":"10.1016/j.jaim.2025.101238","DOIUrl":"10.1016/j.jaim.2025.101238","url":null,"abstract":"<div><h3>Background</h3><div>The human multidrug resistant efflux transporter p-glycoprotein plays a crucial role in the pharmacokinetics of xenobiotics, mediating their elimination from systemic circulation. Its overexpression contributes to multidrug resistance, posing challenges to effective therapeutic interventions.</div></div><div><h3>Objectives</h3><div>This study integrates Ayurvedic and contemporary biomedical research to investigate hotspot residues involved in the interaction of p-glycoprotein with bioactives from medicinal herbs to enhance the understanding of its substrate recognition and transport mechanisms.</div></div><div><h3>Material and methods</h3><div>The 3D structure of 6C0V was docked with 789 herbal ligand molecules utilizing the CDOCKER programme in Biovia Discovery Studio (version 4.5, 2021), revealing key residues involved in binding interactions. Alanine scanning mutagenesis was performed to evaluate the functional importance of these residues by analyzing changes in binding affinity through molecular docking.</div></div><div><h3>Result</h3><div>The study identified residues Ser979, Glu972, Leu332, Phe336, Leu976, Thr76, Leu975, Gly737 and Phe732 as potential hotspots for binding and inhibition of ligand efflux into the extracellular compartment. Targeting these energetically important residues with herbal compounds can guide the development of small-molecule drugs that bind with high specificity and reduce off-target interactions, minimizing undesirable side effects.</div></div><div><h3>Conclusion</h3><div>This study provides insight into the structural basis of p-glycoprotein-herbal ligand interactions, aiding in the design of specific plant-based inhibitors for overcoming multidrug resistance in treatment of chronic diseases.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101238"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145409278","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ayurvedic management for Epidermolysis bullosa - A case report 阿育吠陀治疗大疱性表皮松解症1例报告。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-11-01 Epub Date: 2025-11-11 DOI: 10.1016/j.jaim.2025.101255
K.M. Pratap Shankar , Midhuna Mohan K
Epidermolysis bullosa (EB) is an inherited or auto-immunity-mediated, heterogeneous group of rare genetic dermatoses characterized by fragile skin and mucosae with blister formation induced by minimal trauma. Junctional Epidermolysis Bullosa (JEB) is an autosomal recessive inherited subtype of EB with higher chances of malnutrition and nail involvement. Considering the key factors such as genetic disposition, chronicity, pathology, involvement of deeper tissues, and complexities, EB may be considered as Kustha (spectrum of diseases of the integumentary system) from an Ayurvedic perspective. A 34-year-old male patient diagnosed with JEB presented with a history of persistent non-healing ulcers, recurrent blisters, and bullae, usually occurring after minor trauma since the age of three months. The ulcers, scars, and lesions were widespread, covering approximately two-thirds of the body. After a thorough understanding of the Ayurvedic pathology of the disease, Shamana (pacifying therapy) and Shodhana (purificatory therapy) procedures were administered. Later, raktamoshana (Blood-letting through venesection and jalaukavacharana) was also employed. During the treatment and follow-up period, the episodes of new blister formations drastically reduced, and the ulcer formed from occasional blisters healed quickly without crusting. There was a considerable reduction in wound surface area. The patient's personal and social interactions improved. Quality of Life assessed through the Dermatology Life Quality Index (DLQI) showed improvement. The present case of JEB was effectively managed using various Ayurvedic treatment modalities. Understanding the Ayurvedic pathology and tailoring treatment strategies can yield better results in chronic, debilitating autoimmune dermatological conditions such as EB.
大疱性表皮松解症(EB)是一种遗传性或自身免疫介导的异质性罕见遗传性皮肤病,其特征是皮肤和粘膜脆弱,轻微创伤引起水疱形成。结性大疱性表皮松解症(JEB)是一种常染色体隐性遗传的EB亚型,有较高的营养不良和累及指甲的机会。考虑到遗传倾向、慢性、病理、深层组织的参与和复杂性等关键因素,从阿育吠陀的角度来看,EB可能被认为是Kustha(肠道系统疾病谱系)。确诊为JEB的34岁男性患者,自3个月以来常出现持续不愈合的溃疡、复发性水疱和大疱病史。溃疡、疤痕和病变分布广泛,覆盖了大约三分之二的身体。在彻底了解了阿育吠陀的疾病病理后,进行了Shamana(安抚疗法)和Shodhana(净化疗法)程序。后来,raktamoshana(通过静脉切开和jalaukavacharana放血)也被采用。在治疗和随访期间,新水疱形成的发作急剧减少,偶尔水疱形成的溃疡迅速愈合,无结痂。创面面积有相当大的减少。病人的个人和社会交往得到改善。通过皮肤生活质量指数(DLQI)评估的生活质量显示出改善。使用各种阿育吠陀治疗方式有效地管理了本病例的JEB。了解阿育吠陀的病理和量身定制的治疗策略可以产生更好的效果,慢性,衰弱的自身免疫性皮肤病,如EB。
{"title":"Ayurvedic management for Epidermolysis bullosa - A case report","authors":"K.M. Pratap Shankar ,&nbsp;Midhuna Mohan K","doi":"10.1016/j.jaim.2025.101255","DOIUrl":"10.1016/j.jaim.2025.101255","url":null,"abstract":"<div><div>Epidermolysis bullosa (EB) is an inherited or auto-immunity-mediated, heterogeneous group of rare genetic dermatoses characterized by fragile skin and mucosae with blister formation induced by minimal trauma. Junctional Epidermolysis Bullosa (JEB) is an autosomal recessive inherited subtype of EB with higher chances of malnutrition and nail involvement. Considering the key factors such as genetic disposition, chronicity, pathology, involvement of deeper tissues, and complexities, EB may be considered as <em>Kustha</em> (spectrum of diseases of the integumentary system) from an Ayurvedic perspective. A 34-year-old male patient diagnosed with JEB presented with a history of persistent non-healing ulcers, recurrent blisters, and bullae, usually occurring after minor trauma since the age of three months. The ulcers, scars, and lesions were widespread, covering approximately two-thirds of the body. After a thorough understanding of the Ayurvedic pathology of the disease, <em>Shamana</em> (pacifying therapy) and <em>Shodhana</em> (purificatory therapy) procedures were administered. Later, <em>raktamoshana</em> (Blood-letting through venesection and <em>jalaukavacharana</em>) was also employed. During the treatment and follow-up period, the episodes of new blister formations drastically reduced, and the ulcer formed from occasional blisters healed quickly without crusting. There was a considerable reduction in wound surface area. The patient's personal and social interactions improved. Quality of Life assessed through the Dermatology Life Quality Index (DLQI) showed improvement. The present case of JEB was effectively managed using various Ayurvedic treatment modalities. Understanding the Ayurvedic pathology and tailoring treatment strategies can yield better results in chronic, debilitating autoimmune dermatological conditions such as EB.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 6","pages":"Article 101255"},"PeriodicalIF":1.9,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145504412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pedagogy experiments for Ayush academia 阿尤什学术界的教育学实验。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 Epub Date: 2025-09-18 DOI: 10.1016/j.jaim.2025.101273
Girish Tillu
{"title":"Pedagogy experiments for Ayush academia","authors":"Girish Tillu","doi":"10.1016/j.jaim.2025.101273","DOIUrl":"10.1016/j.jaim.2025.101273","url":null,"abstract":"","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 5","pages":"Article 101273"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145091468","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of an instrument for screening mental health based on Ayurvedic concept of Triguna 开发一种基于阿育吠陀心理健康概念的心理健康筛查工具
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 Epub Date: 2025-08-06 DOI: 10.1016/j.jaim.2025.101175
K.N. Ananda Lakshmy , M.A. Shajahan
<div><h3>Background</h3><div>As the bio-regulatory principles (<em>Dosha</em>) are the essential components of the body, the three attributes (<em>Triguna</em>)-<em>Satva, Raja</em>, and <em>Tamas</em> are the crucial components of the mind that determine an individual's mental status. Though <em>Triguna</em>-based psychological assessment tools are available, there are no standardized tools to evaluate mental health using this unique Ayurvedic approach.So this research was undertaken to create a simple, self-administering instrument for screening mental health based on Ayurvedic concept-<em>Triguna</em>.</div></div><div><h3>Objective</h3><div>To develop a simple, reliable, and valid self-administering instrument based on <em>Triguna</em> concept of Ayurvedic classics for screening mental health.</div></div><div><h3>Methods</h3><div>Standard steps to develop the instrument -Conceptualization, item generation, item selection, item wording, Translation-back translation, pre-test, pilot study, Test-retest were done before the final administration of the draft instrument. Reliability and validity testing were carried out. Reliability assessment included Test-retest and internal consistency. Face, content, construct, criterion and convergent validity were done as part of the validity assessment. Exploratory factor analysis using Principal Component Analysis with Varimax rotation was employed for construct validation and item reduction. A cross-sectional study employing a stratified, multi-stage cluster sampling technique was conducted among 400 participants aged 20–40 years, representing rural, urban and coastal areas of Thiruvananthapuram, Kerala, India. The criterion validity of the newly developed tool was assessed against the WHO Subjective Well-being Inventory(SUBI).The reference standard, evaluated for its diagnostic properties including sensitivity, specificity, predictive values, and likelihood ratios, was administered alongside the draft instrument. After appropriate analyses, a 38-item self-administering instrument was developed and named as Mental Health Assessment Scale with <em>Triguna</em> (MHAS-TG). Hypothesis validation and construct validity were assessed using diverse community samples, comprising 100 individuals from various geographical areas of Kannur District, 100 students from NIT Calicut (Kozhikode) and 50 ex-convicts from Kannur District.</div></div><div><h3>Results</h3><div>The newly developed 38-item Mental Health self-Assessment Scale with <em>Triguna</em> (MHAS-TG) is presented as a discriminating tool that showed high Test-retest (Intra Class Correlation coefficient - 0.8) and Internal consistency reliability (Cronbach's alpha = 0.9). The tool had adequate face validity and content validity (Content validity index- 0.84). Construct validity by Exploratory factor analysis yielded 38 items of 9-factor solution with a cumulative variance of 58.06 %. The self-administering tool with a score range of 0–114 derived a cut-off sc
由于生物调节原理(Dosha)是身体的基本组成部分,三属性(Triguna)-Satva, Raja和Tamas是决定个人精神状态的关键组成部分。虽然基于triguna的心理评估工具是可用的,但没有标准化的工具来评估使用这种独特的阿育吠陀方法的心理健康。因此,这项研究是为了创造一个简单的,自我管理的工具来筛查心理健康基于阿育吠陀的概念- triguna。目的研制一种简单、可靠、有效的基于阿育吠陀经典Triguna概念的心理健康筛查自用药仪。方法在最终发放前,按标准步骤进行量表的编制——概念化、项目生成、项目选择、项目措辞、翻译回译、预试、中试、复试。进行信度和效度检验。可靠性评估包括重测和内部一致性。效度评估包括面、内容、结构、标准和收敛效度。探索性因子分析采用主成分分析和方差旋转进行结构验证和项目缩减。采用分层、多阶段整群抽样技术的横断面研究对400名年龄在20-40岁之间的参与者进行了研究,这些参与者代表了印度喀拉拉邦蒂鲁凡南得普兰邦的农村、城市和沿海地区。根据世卫组织主观幸福感量表(SUBI)评估新开发工具的标准效度。参考标准,评估其诊断特性,包括敏感性、特异性、预测值和似然比,与草案工具一起使用。经过适当的分析,编制了一套38项的自我管理量表,并命名为心理健康评估量表(mahas - tg)。假设验证和结构效度评估采用不同的社区样本,包括来自坎努尔地区不同地理区域的100名个人,来自卡利科特(科日科德)NIT的100名学生和来自坎努尔地区的50名前罪犯。结果新编制的38项Triguna心理健康自评量表(MHAS-TG)具有较高的重测(类内相关系数- 0.8)和内部一致性信度(Cronbach's alpha = 0.9)。该工具具有足够的表面效度和内容效度(内容效度指数- 0.84)。探索性因子分析产生38项9因子解,累积方差为58.06%。评分范围为0-114的自我给药工具根据敏感性和特异性得出了40分和80分的临界值。得分低于40分为心理健康不良,41-80分为心理健康中等,81分以上为心理健康良好。受试者工作特征曲线分析灵敏度为75.36%,特异性为78.18。该工具的平均使用时间为10分钟。对印度喀拉拉邦Thiruvananthapuram地区400人进行心理健康筛查的结果如下:28.25%的人心理健康状况良好,63.5%的人心理健康状况中等,8.5%的人心理健康状况不佳。在坎努尔县进行的再验证表明,17%的人心理健康状况良好,75%的人心理健康状况中等,8%的人心理健康状况较差。在科日科德,16%的人心理健康状况良好,74%的人心理健康状况一般,10%的人心理健康状况较差。在前罪犯中,8%的人心理健康状况良好,67%的人心理健康状况中等,25%的人心理健康状况不佳。独立t检验显示差异有统计学意义(p <;0.05)。弱正相关分析(p <;Satva评分与Rajo Guna评分呈显著负相关(p <;0.01)与Tamo Guna呈正相关(p <;Rajo和Tamo Guna的比值为0.01。结论mhas - tg是一种基于Triguna概念的有效、可靠的38项自我管理工具。该工具具有影响心理健康的风险和保护因素,是一种快速简便的评估心理健康的筛查工具。在Thiruvananthapuram地区的400名参与者中,该工具的管理显示了它识别精神健康状况不佳的人的能力。Satva-Rajo得分之间呈弱正相关,Satva-Tamo得分之间呈强负相关,Rajo-Tamo得分之间呈中度正相关。
{"title":"Development of an instrument for screening mental health based on Ayurvedic concept of Triguna","authors":"K.N. Ananda Lakshmy ,&nbsp;M.A. Shajahan","doi":"10.1016/j.jaim.2025.101175","DOIUrl":"10.1016/j.jaim.2025.101175","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Background&lt;/h3&gt;&lt;div&gt;As the bio-regulatory principles (&lt;em&gt;Dosha&lt;/em&gt;) are the essential components of the body, the three attributes (&lt;em&gt;Triguna&lt;/em&gt;)-&lt;em&gt;Satva, Raja&lt;/em&gt;, and &lt;em&gt;Tamas&lt;/em&gt; are the crucial components of the mind that determine an individual's mental status. Though &lt;em&gt;Triguna&lt;/em&gt;-based psychological assessment tools are available, there are no standardized tools to evaluate mental health using this unique Ayurvedic approach.So this research was undertaken to create a simple, self-administering instrument for screening mental health based on Ayurvedic concept-&lt;em&gt;Triguna&lt;/em&gt;.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Objective&lt;/h3&gt;&lt;div&gt;To develop a simple, reliable, and valid self-administering instrument based on &lt;em&gt;Triguna&lt;/em&gt; concept of Ayurvedic classics for screening mental health.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;Standard steps to develop the instrument -Conceptualization, item generation, item selection, item wording, Translation-back translation, pre-test, pilot study, Test-retest were done before the final administration of the draft instrument. Reliability and validity testing were carried out. Reliability assessment included Test-retest and internal consistency. Face, content, construct, criterion and convergent validity were done as part of the validity assessment. Exploratory factor analysis using Principal Component Analysis with Varimax rotation was employed for construct validation and item reduction. A cross-sectional study employing a stratified, multi-stage cluster sampling technique was conducted among 400 participants aged 20–40 years, representing rural, urban and coastal areas of Thiruvananthapuram, Kerala, India. The criterion validity of the newly developed tool was assessed against the WHO Subjective Well-being Inventory(SUBI).The reference standard, evaluated for its diagnostic properties including sensitivity, specificity, predictive values, and likelihood ratios, was administered alongside the draft instrument. After appropriate analyses, a 38-item self-administering instrument was developed and named as Mental Health Assessment Scale with &lt;em&gt;Triguna&lt;/em&gt; (MHAS-TG). Hypothesis validation and construct validity were assessed using diverse community samples, comprising 100 individuals from various geographical areas of Kannur District, 100 students from NIT Calicut (Kozhikode) and 50 ex-convicts from Kannur District.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;The newly developed 38-item Mental Health self-Assessment Scale with &lt;em&gt;Triguna&lt;/em&gt; (MHAS-TG) is presented as a discriminating tool that showed high Test-retest (Intra Class Correlation coefficient - 0.8) and Internal consistency reliability (Cronbach's alpha = 0.9). The tool had adequate face validity and content validity (Content validity index- 0.84). Construct validity by Exploratory factor analysis yielded 38 items of 9-factor solution with a cumulative variance of 58.06 %. The self-administering tool with a score range of 0–114 derived a cut-off sc","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 5","pages":"Article 101175"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144779299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hashimoto's thyroiditis and hypothyroidism, treated with Shamana Chikitsa principles of Panduroga – A case report 用潘氏法治疗桥本甲状腺炎和甲状腺功能减退1例
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 Epub Date: 2025-08-30 DOI: 10.1016/j.jaim.2025.101172
P.K.V. Anand, Vaishali Deshpande
Hypothyroidism as a sequel to Hashimoto's thyroiditis is a very common thyroid illness. The conventional treatment is replacement of thyroid hormone to compensate insufficient production from the gland. The clinical features manifested is of widely variable intensity and may not be proportionate always to the blood levels of hormones. The disease does not have a direct mention in Ayurvedic classics. In such instances, treatment principle is adopted from the principles of treatment mentioned for those diseases which holds a similarity in etiopathogenesis, based on the clinical presentations and Dosha-Dooshya analysis. Thus, treatment principles of various diseases such as Galagandam, Agnimandyam, Sthoulyam etc., are being used for the treatment of thyroid diseases. A case of hypothyroidism presented with clinical features similar to Pandurogam was managed with the medicines described in the context of Pandurogam and Sopham. Higher TSH levels were brought to normal limits and high anti thyroid peroxidase level was reduced with a set of Ayurvedic medicines for a longer duration. Keeping away from the popular translation of Pandurogam as Anemia, a symptom oriented diagnostic work up based exclusively on the Ayurvedic classics, followed by symptom-oriented selection of medicines suited to the diagnosis is effective in reducing both symptoms and blood values. This gives the hope of managing hypothyroidism with alternate treatment methods other than supplementation of hormone for lifelong.
甲状腺功能减退症是桥本甲状腺炎的后遗症,是一种非常常见的甲状腺疾病。传统的治疗方法是更换甲状腺激素,以弥补腺体分泌不足。所表现的临床特征的强度变化很大,可能并不总是与血液中的激素水平成比例。阿育吠陀经典中并没有直接提到这种疾病。在这种情况下,根据临床表现和Dosha-Dooshya分析,采用的治疗原则是针对那些在发病机制上具有相似性的疾病所提到的治疗原则。因此,诸如Galagandam、Agnimandyam、Sthoulyam等各种疾病的治疗原则被用于治疗甲状腺疾病。一例甲状腺功能减退症的临床特征与Pandurogam相似,用Pandurogam和Sopham中描述的药物进行治疗。较高的TSH水平被控制在正常范围内,高抗甲状腺过氧化物酶水平通过一组阿育吠陀药物持续较长时间而降低。避免将Pandurogam翻译为贫血,以症状为导向的诊断工作完全基于阿育吠陀经典,然后以症状为导向选择适合诊断的药物,有效地减少了症状和血液值。这给了管理甲状腺功能减退的希望与替代治疗方法,而不是补充终身激素。
{"title":"Hashimoto's thyroiditis and hypothyroidism, treated with Shamana Chikitsa principles of Panduroga – A case report","authors":"P.K.V. Anand,&nbsp;Vaishali Deshpande","doi":"10.1016/j.jaim.2025.101172","DOIUrl":"10.1016/j.jaim.2025.101172","url":null,"abstract":"<div><div>Hypothyroidism as a sequel to Hashimoto's thyroiditis is a very common thyroid illness. The conventional treatment is replacement of thyroid hormone to compensate insufficient production from the gland. The clinical features manifested is of widely variable intensity and may not be proportionate always to the blood levels of hormones. The disease does not have a direct mention in Ayurvedic classics. In such instances, treatment principle is adopted from the principles of treatment mentioned for those diseases which holds a similarity in etiopathogenesis, based on the clinical presentations and Dosha-Dooshya analysis. Thus, treatment principles of various diseases such as Galagandam, Agnimandyam, Sthoulyam etc., are being used for the treatment of thyroid diseases. A case of hypothyroidism presented with clinical features similar to Pandurogam was managed with the medicines described in the context of Pandurogam and Sopham. Higher TSH levels were brought to normal limits and high anti thyroid peroxidase level was reduced with a set of Ayurvedic medicines for a longer duration. Keeping away from the popular translation of Pandurogam as Anemia, a symptom oriented diagnostic work up based exclusively on the Ayurvedic classics, followed by symptom-oriented selection of medicines suited to the diagnosis is effective in reducing both symptoms and blood values. This gives the hope of managing hypothyroidism with alternate treatment methods other than supplementation of hormone for lifelong.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 5","pages":"Article 101172"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144916669","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prakriti elucidates the inter-individual variability in coronary artery disease risk-predicting biomarkers: A tertiary care hospital-based case control study Prakriti阐明了冠状动脉疾病风险预测生物标志物的个体间变异性:一项基于三级保健医院的病例对照研究
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 Epub Date: 2025-08-19 DOI: 10.1016/j.jaim.2025.101178
Pamila Dua , Bhavana Prasher , Sandeep Seth , Shivam Pandey , Subir Kumar Maulik , K.H. Reeta

Background

Several biochemical tests and biomarkers are well-known for the assessment of risk towards coronary artery disease (CAD). However, conflicting results pose a significant challenge probably due to phenotypic heterogeneity. In Ayurveda, individuals are classified into phenotypes- Prakriti, which helps in predicting an individual's susceptibility to disease, its prognosis and selection of therapy. In the present study, an attempt was made to overcome this challenge with an aim to identify the association between different constitution types as mentioned in Ayurveda with biochemical markers for precisely predicting the risks for CAD.

Methods

200 clinically stable CAD patients and 100 healthy controls were recruited from the Cardiology OPD, AIIMS, New Delhi, India. A comprehensive set of tests to incorporate various aspects of CAD pathophysiology was performed. Assessment of Prakriti was done clinically and with AI/ML algorithm based validated questionnaire.

Results

The monocyte-lymphocyte ratio (MLR), fasting blood sugar, urea, creatinine, uric acid, and NT-pro BNP were significantly higher in CAD patients as compared to healthy controls. Prakriti stratification revealed maximum number of patients with Kapha Prakriti. MLR and IL-6 (associated with inflammatory and peripheral endothelial dysfunction) were high in Vata patients; diabetic control (associated with plaque instability and malfunctioned RAAS) was poor in Kapha patients and NT-pro BNP (associated with myocardial hypoxia) was higher in Pitta patients.

Conclusion

Though, several biochemical parameters were associated with risks for CAD, Prakriti classification provided more insights into the precise risks. This dual approach may help in guiding personalized treatment options in CAD management.
背景:几种生物化学测试和生物标志物在评估冠状动脉疾病(CAD)风险方面是众所周知的。然而,可能由于表型异质性,相互矛盾的结果提出了重大挑战。在阿育吠陀,个体被划分为表型——Prakriti,这有助于预测个体对疾病的易感性、预后和治疗选择。在目前的研究中,我们试图克服这一挑战,目的是确定阿育吠陀中提到的不同体质类型与精确预测CAD风险的生化标志物之间的联系。方法从印度新德里AIIMS心内科OPD招募临床稳定的冠心病患者200例和健康对照100例。进行了一套综合CAD病理生理学各个方面的测试。临床评估Prakriti,并采用基于AI/ML算法的有效问卷。结果冠心病患者的单核细胞淋巴细胞比(MLR)、空腹血糖、尿素、肌酐、尿酸、NT-pro BNP均显著高于健康对照组。Prakriti分层显示Kapha Prakriti患者最多。Vata患者的MLR和IL-6(与炎症和外周内皮功能障碍相关)较高;Kapha患者的糖尿病控制(与斑块不稳定和功能失调的RAAS相关)较差,而Pitta患者的NT-pro BNP(与心肌缺氧相关)较高。结论:虽然一些生化参数与冠心病的风险相关,但Prakriti分类提供了更准确的风险。这种双重方法可能有助于指导CAD管理中的个性化治疗选择。
{"title":"Prakriti elucidates the inter-individual variability in coronary artery disease risk-predicting biomarkers: A tertiary care hospital-based case control study","authors":"Pamila Dua ,&nbsp;Bhavana Prasher ,&nbsp;Sandeep Seth ,&nbsp;Shivam Pandey ,&nbsp;Subir Kumar Maulik ,&nbsp;K.H. Reeta","doi":"10.1016/j.jaim.2025.101178","DOIUrl":"10.1016/j.jaim.2025.101178","url":null,"abstract":"<div><h3>Background</h3><div>Several biochemical tests and biomarkers are well-known for the assessment of risk towards coronary artery disease (CAD). However, conflicting results pose a significant challenge probably due to phenotypic heterogeneity. In Ayurveda, individuals are classified into phenotypes- <em>Prakriti,</em> which helps in predicting an individual's susceptibility to disease, its prognosis and selection of therapy. In the present study, an attempt was made to overcome this challenge with an aim to identify the association between different constitution types as mentioned in Ayurveda with biochemical markers for precisely predicting the risks for CAD.</div></div><div><h3>Methods</h3><div>200 clinically stable CAD patients and 100 healthy controls were recruited from the Cardiology OPD, AIIMS, New Delhi, India. A comprehensive set of tests to incorporate various aspects of CAD pathophysiology was performed. Assessment of <em>Prakriti</em> was done clinically and with AI/ML algorithm based validated questionnaire.</div></div><div><h3>Results</h3><div>The monocyte-lymphocyte ratio (MLR), fasting blood sugar, urea, creatinine, uric acid, and NT-pro BNP were significantly higher in CAD patients as compared to healthy controls. <em>Prakriti</em> stratification revealed maximum number of patients with <em>Kapha Prakriti</em>. MLR and IL-6 (associated with inflammatory and peripheral endothelial dysfunction) were high in <em>Vata</em> patients; diabetic control (associated with plaque instability and malfunctioned RAAS) was poor in <em>Kapha</em> patients and NT-pro BNP (associated with myocardial hypoxia) was higher in <em>Pitta</em> patients.</div></div><div><h3>Conclusion</h3><div>Though, several biochemical parameters were associated with risks for CAD, <em>Prakriti</em> classification provided more insights into the precise risks. This dual approach may help in guiding personalized treatment options in CAD management.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 5","pages":"Article 101178"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144865078","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integrating macro-microscopy, DNA barcoding and HPTLC for quality assessment of berberine containing botanicals traded as Maramanjal/Daruharidra 结合宏观显微镜、DNA条形码和HPTLC技术对以Maramanjal/Daruharidra交易的含有小檗碱的植物药进行质量评价
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 Epub Date: 2025-09-12 DOI: 10.1016/j.jaim.2025.101192
Sunil Kumar Koppala Narayana , Pushkar Kaira , Mahima Karthikeyan , Murugammal Shanmugam , Susikumar Sundharamoorthy , Remya Andalil , Divya Kallingil Gopi , Radha Prakasam , Shakila Ramachandran , Kanagarajan Arumugam

Background

Daruharidra/Maramanjal is one of the most popular shrub used in Ayurveda, Siddha and other Indian medicinal systems. More than one botanical source is traded under this name, predominantly Berberis aristata and Coscinium fenestratum with an annual trade of 1000–2000 metric tonnes. The herbal drug trade is often reported with misidentification, adulteration and/or substitution issues due to morphological resemblance and confusion in vernacular names. This work aimed to integrate macro-microscopic, DNA marker strategies and phytochemical assay to differentiate Berberis aristata from its traded sources.

Material and methods

Thirteen marketed samples and one authentic field sample from natural habitat were collected from various regions of the Indian market under the trade name Maramanjal/Daruharidra. The traditional identification methods included macro-microscopic and phytochemical screening by High-Performance Thin Layer Chromatography (HPTLC). Additionally, DNA barcode-based molecular identification and phylogenetic analysis were done using the ITS2 (Internal Transcribed Spacer 2) marker.

Results

The macroscopic observations revealed 80 % ad-mixing of various allied botanicals in addition to accepted north Indian and south Indian sources such as B. aristata and C. fenestratum respectively. DNA barcoding enabled the identification of genuine and adulterated raw drugs from the collected samples. The HPTLC quantification revealed the presence of berberine in all 14 samples varying from 1.12 % to 26.33 %.

Conclusions

The macro-micro, HPTLC, and DNA barcoding helped in the identification of adulteration and substitution practices in this highly traded botanical drug. DNA barcoding can prove an effective tool for discovering the adulteration and substitution of Maramanjal/Daruharidra and this is its first report on the application of morphology, microscopy, phytochemical analysis, and DNA markers in differentiating these traded species.
daruharidra /Maramanjal是阿育吠陀、悉达和其他印度医疗系统中最受欢迎的灌木之一。以这个名字进行交易的植物来源不止一种,主要是小檗(Berberis aristata)和黄连木(coscium fenestratum),年交易量为1000-2000公吨。由于形态相似和白话名称混淆,草药贸易经常报告有误认、掺假和/或替代问题。本研究旨在整合宏观显微镜、DNA标记策略和植物化学分析方法来区分马兜铃小檗及其贸易来源。材料和方法从印度市场的不同地区以商品名Maramanjal/Daruharidra收集了13个市场样本和一个来自自然栖息地的真实实地样本。传统的鉴定方法包括宏观显微镜和高效薄层色谱(HPTLC)筛选。此外,利用ITS2 (Internal transcripsed Spacer 2)标记进行了基于DNA条形码的分子鉴定和系统发育分析。结果宏观观察结果显示,除了印度北部的马兜铃和印度南部的凤尾草等公认的植物来源外,还有80%的植物混合在一起。DNA条形码能够从收集的样品中识别真假原料药。hplc定量分析显示,14份样品中小檗碱的含量在1.12% ~ 26.33%之间。结论宏微观、HPTLC和DNA条形码技术有助于鉴别该药材的掺假和替代行为。DNA条形码可以证明是一种有效的工具,用于发现掺假和替代的Maramanjal/Daruharidra,这是其首次应用形态学,显微镜,植物化学分析和DNA标记来区分这些交易物种。
{"title":"Integrating macro-microscopy, DNA barcoding and HPTLC for quality assessment of berberine containing botanicals traded as Maramanjal/Daruharidra","authors":"Sunil Kumar Koppala Narayana ,&nbsp;Pushkar Kaira ,&nbsp;Mahima Karthikeyan ,&nbsp;Murugammal Shanmugam ,&nbsp;Susikumar Sundharamoorthy ,&nbsp;Remya Andalil ,&nbsp;Divya Kallingil Gopi ,&nbsp;Radha Prakasam ,&nbsp;Shakila Ramachandran ,&nbsp;Kanagarajan Arumugam","doi":"10.1016/j.jaim.2025.101192","DOIUrl":"10.1016/j.jaim.2025.101192","url":null,"abstract":"<div><h3>Background</h3><div><em>Daruharidra/Maramanjal</em> is one of the most popular shrub used in Ayurveda, Siddha and other Indian medicinal systems. More than one botanical source is traded under this name, predominantly <em>Berberis aristata</em> and <em>Coscinium fenestratum</em> with an annual trade of 1000–2000 metric tonnes. The herbal drug trade is often reported with misidentification, adulteration and/or substitution issues due to morphological resemblance and confusion in vernacular names. This work aimed to integrate macro-microscopic, DNA marker strategies and phytochemical assay to differentiate <em>Berberis aristata</em> from its traded sources.</div></div><div><h3>Material and methods</h3><div>Thirteen marketed samples and one authentic field sample from natural habitat were collected from various regions of the Indian market under the trade name <em>Maramanjal/Daruharidra</em>. The traditional identification methods included macro-microscopic and phytochemical screening by High-Performance Thin Layer Chromatography (HPTLC). Additionally, DNA barcode-based molecular identification and phylogenetic analysis were done using the ITS2 (Internal Transcribed Spacer 2) marker.</div></div><div><h3>Results</h3><div>The macroscopic observations revealed 80 % ad-mixing of various allied botanicals in addition to accepted north Indian and south Indian sources such as <em>B. aristata</em> and <em>C. fenestratum</em> respectively. DNA barcoding enabled the identification of genuine and adulterated raw drugs from the collected samples. The HPTLC quantification revealed the presence of berberine in all 14 samples varying from 1.12 % to 26.33 %.</div></div><div><h3>Conclusions</h3><div>The macro-micro, HPTLC, and DNA barcoding helped in the identification of adulteration and substitution practices in this highly traded botanical drug. DNA barcoding can prove an effective tool for discovering the adulteration and substitution of <em>Maramanjal/Daruharidra</em> and this is its first report on the application of morphology, microscopy, phytochemical analysis, and DNA markers in differentiating these traded species.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 5","pages":"Article 101192"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145044615","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding Atherosclerotic Cardiovascular disease in the light of Ayurveda 从阿育吠陀的角度理解动脉粥样硬化性心血管疾病。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 Epub Date: 2025-09-18 DOI: 10.1016/j.jaim.2025.101186
Maanasi Menon , Sushma Naranappa Salethoor , Thushara Madathil , Akhilesh Shukla
Atherosclerotic cardiovascular disease (ASCVD) is the malady that claims most human lives around the world by literally cutting off their heart's blood supply. Unwholesome diet, sedentary lifestyle and psychological stress are the major risk factors leading to this condition. Even with technological and medical advancements, the burden of this disease has only aggravated further especially with the COVID pandemic also contributing to trigger this condition. There is an urgent need to find better solutions to combat this disease in such circumstances. The Indian traditional healthcare system, Ayurveda has a unique perspective of the heart and heart disease which when understood parallelly along with modern medical knowledge may offer better solutions. The descriptions of Kaphaja Hridroga in Ayurveda can be correlated to ASCVD, and this article is an effort to develop a synergistic understanding of the aetio-pathogenesis of ASCVD in the light of Ayurveda. Ayurveda management principles give more emphasis on prevention and non-pharmacological approaches such as diet and lifestyle modifications along with medical management and these principles of management of Hridroga can be tactfully integrated into conventional therapy for providing a more wholesome care.
动脉粥样硬化性心血管疾病(ASCVD)是一种夺走世界上大多数人生命的疾病,它实际上切断了他们的心脏血液供应。不健康的饮食、久坐不动的生活方式和心理压力是导致这种情况的主要风险因素。即使在技术和医学进步的情况下,这种疾病的负担只会进一步加重,特别是COVID大流行也会引发这种情况。在这种情况下,迫切需要找到更好的办法来防治这一疾病。印度传统医疗保健系统,阿育吠陀对心脏和心脏病有独特的看法,当与现代医学知识并行理解时,可能会提供更好的解决方案。阿育吠陀中Kaphaja Hridroga的描述可以与ASCVD相关联,本文旨在从阿育吠陀的角度对ASCVD的运动发病机制进行协同理解。阿育吠陀的管理原则更加强调预防和非药物方法,如饮食和生活方式的改变以及医疗管理,这些管理原则可以巧妙地融入传统治疗中,以提供更健康的护理。
{"title":"Understanding Atherosclerotic Cardiovascular disease in the light of Ayurveda","authors":"Maanasi Menon ,&nbsp;Sushma Naranappa Salethoor ,&nbsp;Thushara Madathil ,&nbsp;Akhilesh Shukla","doi":"10.1016/j.jaim.2025.101186","DOIUrl":"10.1016/j.jaim.2025.101186","url":null,"abstract":"<div><div>Atherosclerotic cardiovascular disease (ASCVD) is the malady that claims most human lives around the world by literally cutting off their heart's blood supply. Unwholesome diet, sedentary lifestyle and psychological stress are the major risk factors leading to this condition. Even with technological and medical advancements, the burden of this disease has only aggravated further especially with the COVID pandemic also contributing to trigger this condition. There is an urgent need to find better solutions to combat this disease in such circumstances. The Indian traditional healthcare system, Ayurveda has a unique perspective of the heart and heart disease which when understood parallelly along with modern medical knowledge may offer better solutions. The descriptions of <em>Kaphaja Hridroga</em> in Ayurveda can be correlated to ASCVD, and this article is an effort to develop a synergistic understanding of the aetio-pathogenesis of ASCVD in the light of Ayurveda. Ayurveda management principles give more emphasis on prevention and non-pharmacological approaches such as diet and lifestyle modifications along with medical management and these principles of management of <em>Hridroga</em> can be tactfully integrated into conventional therapy for providing a more wholesome care.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 5","pages":"Article 101186"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145091455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of Oligo-teratospermia with Vajikarana Chitkitsa resulting in healthy natural conception: A case report. 少精畸形精子症合并Vajikarana Chitkitsa致健康自然受孕1例。
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 Epub Date: 2025-08-07 DOI: 10.1016/j.jaim.2025.101190
Swarda R Uppin, T U Aravinth

Oligo-teratozoospermia is a condition affecting the normal sperm count and morphology leading to male factor infertility, majorly resulting due to improper lifestyle adaptations. In Ayurveda literature, the condition is well elaborated as Ksheenashukra having specified treatment modalities. This paper presents a case of infertile couple where in the male was diagnosed with Oligo-teratozoospermia, and was advised for ART due to teratogenecity. The patient approached Ayurveda fertility centre and was subjected to Ayurveda treatment with initial counseling, followed by Shodhana chikitsa and 2 courses of Vajikarana aushadhi prayoga. Within 3 months, the outcome resulted from Oligo-teratozoospermia to normozoospermia and the partner conceived within 2 cycles. The female experienced a safe and healthy antenatal phase and the couple was blessed with a baby boy.

少畸形精子症是一种影响正常精子数量和形态导致男性因素不育的疾病,主要是由于不适当的生活方式适应造成的。在阿育吠陀文献中,这种情况被很好地阐述为Ksheenashukra有特定的治疗方式。本文报告一对不育夫妇,其中男性被诊断为少畸形精子症,并因致畸而建议进行抗逆转录病毒治疗。患者来到阿育吠陀生育中心,接受阿育吠陀治疗并进行初步咨询,随后进行Shodhana chikitsa和2个疗程的Vajikarana aushadhi prayoga。3个月内由少畸形精子症转为正常精子症,伴侣2个周期内受孕。这名女性经历了一个安全健康的产前阶段,这对夫妇得到了一个男孩。
{"title":"Management of Oligo-teratospermia with Vajikarana Chitkitsa resulting in healthy natural conception: A case report.","authors":"Swarda R Uppin, T U Aravinth","doi":"10.1016/j.jaim.2025.101190","DOIUrl":"10.1016/j.jaim.2025.101190","url":null,"abstract":"<p><p>Oligo-teratozoospermia is a condition affecting the normal sperm count and morphology leading to male factor infertility, majorly resulting due to improper lifestyle adaptations. In Ayurveda literature, the condition is well elaborated as Ksheenashukra having specified treatment modalities. This paper presents a case of infertile couple where in the male was diagnosed with Oligo-teratozoospermia, and was advised for ART due to teratogenecity. The patient approached Ayurveda fertility centre and was subjected to Ayurveda treatment with initial counseling, followed by Shodhana chikitsa and 2 courses of Vajikarana aushadhi prayoga. Within 3 months, the outcome resulted from Oligo-teratozoospermia to normozoospermia and the partner conceived within 2 cycles. The female experienced a safe and healthy antenatal phase and the couple was blessed with a baby boy.</p>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 5","pages":"101190"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12355026/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144804178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A case report on Ayurvedic management of progressive bulbar palsy-A rare amyotrophic lateral sclerosis phenotype 阿育吠陀治疗进行性球性麻痹1例报告-罕见的肌萎缩性侧索硬化表型
IF 1.9 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE Pub Date : 2025-09-01 Epub Date: 2025-09-05 DOI: 10.1016/j.jaim.2025.101176
Sinimol Thekkekkoottumughath Peethambaran , Abhayadev Ashokan , Varanasi Subhose
This case report is the description of a devastating illness, Progressive Bulbar Palsy (PBP) of a sixty-seven years old male patient. He presented with complaints of slurred speech, hearing impairment, generalised weakness of limbs, weakened grip to hold objects in hand, difficulty to walk with normal speed, frequent dizzy feeling while walking, severe fatigue, increased anger, heaviness of head, depression, anxiety, decreased memory and headache for 1 year. When he consulted conventional medicine, in Magnetic Resonance Imaging (MRI) of brain, only ‘Partial empty sella’ and age related mild cerebral atrophy was detected and the patient was diagnosed PBP clinically. They prescribed Riluzole 50 mg tablet twice a day and Fluoxetine 10mg capsules at night time for 3 months, but obtained no relief for symptoms and consulted this Out Patient Department (OPD). In Ayurvedic parlance, PBP resembles conditions like Kaphavruta vata. In this patient, Pittavritavata symptoms like bhrama (∼dizziness) was also present in increased severity. Diagnosis was done with the aid of Gold Coast diagnostic criteria. Internal and external medications with properties alleviating avarana (∼occlusion) of vata by kapha and pitta, shodhana (∼expelling the aggravated doshas and cleanses the body internally), rejuvenating (Rasayana) properties, for overall strengthening of nervous system and musculoskeletal system, enhancing balance and coordination, improving speech and memory were used. The assessment was done before and after the treatment by ‘Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R). The score before and after the treatment was 35 and 45 respectively out of 48. The treatment helped to increase the quality of life exceptionally as symptomatic relief was obtained. As it is a devastating disorder with poor prognosis and most probably will lead to death, it is advisable to repeat the treatments in regular intervals, depending on the recurrence of symptoms, if any.
本病例报告是一个毁灭性的疾病,进行性球麻痹(PBP)的67岁男性患者的描述。其主诉为言语不清、听力障碍、四肢全身性无力、握物能力减弱、正常速度行走困难、行走时常感到头晕、严重疲劳、易怒、头重、抑郁、焦虑、记忆力下降、头痛1年。经常规医学检查,脑磁共振成像(MRI)仅检出“部分鞍区空”及年龄相关性轻度脑萎缩,临床诊断为PBP。服用利鲁唑50 mg片剂,每日2次,氟西汀10mg胶囊,夜间1次,疗程3个月,症状未见缓解,就诊于门诊。在阿育吠陀的说法中,PBP类似于Kaphavruta vata。在该患者中,皮塔夫里塔塔症状如bhrama(~头晕)也出现,且严重程度增加。根据黄金海岸诊断标准进行诊断。使用具有减轻kapha和pitta对vata的avarana(~阻断),shodhana(~排出加重的dosha并在内部清洁身体),恢复活力(Rasayana)特性的内部和外部药物,以全面加强神经系统和肌肉骨骼系统,增强平衡和协调,改善语言和记忆。在治疗前后采用“肌萎缩侧索硬化症功能评定量表-修订版(ALSFRS-R)”进行评估。治疗前后分别为35分和45分(总分48分)。治疗有助于提高生活质量,特别是获得症状缓解。由于这是一种预后不良且极有可能导致死亡的毁灭性疾病,建议根据症状的复发情况(如果有的话)定期重复治疗。
{"title":"A case report on Ayurvedic management of progressive bulbar palsy-A rare amyotrophic lateral sclerosis phenotype","authors":"Sinimol Thekkekkoottumughath Peethambaran ,&nbsp;Abhayadev Ashokan ,&nbsp;Varanasi Subhose","doi":"10.1016/j.jaim.2025.101176","DOIUrl":"10.1016/j.jaim.2025.101176","url":null,"abstract":"<div><div>This case report is the description of a devastating illness, Progressive Bulbar Palsy (PBP) of a sixty-seven years old male patient. He presented with complaints of slurred speech, hearing impairment, generalised weakness of limbs, weakened grip to hold objects in hand, difficulty to walk with normal speed, frequent dizzy feeling while walking, severe fatigue, increased anger, heaviness of head, depression, anxiety, decreased memory and headache for 1 year. When he consulted conventional medicine, in Magnetic Resonance Imaging (MRI) of brain, only ‘Partial empty sella’ and age related mild cerebral atrophy was detected and the patient was diagnosed PBP clinically. They prescribed Riluzole 50 mg tablet twice a day and Fluoxetine 10mg capsules at night time for 3 months, but obtained no relief for symptoms and consulted this Out Patient Department (OPD). In Ayurvedic parlance, PBP resembles conditions like <em>Kaphavruta vata</em>. In this patient, <em>Pittavritavata</em> symptoms like <em>bhrama</em> (∼dizziness) was also present in increased severity. Diagnosis was done with the aid of Gold Coast diagnostic criteria. Internal and external medications with properties alleviating <em>avarana</em> (∼occlusion) of <em>vata</em> by <em>kapha</em> and <em>pitta</em>, <em>shodhana</em> (∼expelling the aggravated doshas and cleanses the body internally), rejuvenating <em>(Rasayana) properties,</em> for overall strengthening of nervous system and musculoskeletal system, enhancing balance and coordination, improving speech and memory were used. The assessment was done before and after the treatment by ‘Amyotrophic Lateral Sclerosis Functional Rating Scale-Revised (ALSFRS-R). The score before and after the treatment was 35 and 45 respectively out of 48. The treatment helped to increase the quality of life exceptionally as symptomatic relief was obtained. As it is a devastating disorder with poor prognosis and most probably will lead to death, it is advisable to repeat the treatments in regular intervals, depending on the recurrence of symptoms, if any.</div></div>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 5","pages":"Article 101176"},"PeriodicalIF":1.9,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144996897","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Ayurveda and Integrative Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1